Tradestie Institutional Equity Comparison Engine

DSGN vs FHTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSGN Overall Edge

DSGN Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Design Therapeutics, Inc. Common Stock (DSGN) driven by superior Momentum & Technical, Options & Structure while FHTX counters with relative strength in Valuation, Growth & Margin. Fundamentally, DSGN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FHTX at N/M Forward P/E and 8.0% operating margin (+924.7% YoY). In options structure, DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against FHTX sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner FHTX
DSGN N/M vs FHTX N/M Fwd P/E
Growth & Margin Winner FHTX
Op Margin 0.0% vs 8.0% ยท YoY +0.0% vs +924.7%
Momentum & Technical Winner DSGN
1Y +40.8% vs -58.5% ยท 52W Pos 30% vs 0%
Options & Structure Winner DSGN
BREAKDOWN (13th %ile IV) vs UNCLASSIFIED (34th %ile IV)
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 63.0 Mom 54.0
FHTX NASDAQ
Foghorn Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$1.81
-12.56% 1D
Market Cap $122.9M
1M Return -2.16%
1Y Return -58.49%
Forward P/E N/M
Unified AI Score
38.2 / 100 SELL
Tech 25.0 Fund 47.0 Flow 50.0 Mom 74.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DSGN +40.79% FHTX -58.49% Spread: +99.28 pp (DSGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DSGN TTM Op. Margin: 0.0% FHTX TTM Op. Margin: 8.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DSGN vs FHTX. Trailing 12-month operating profitability (DSGN 0.0% vs FHTX 8.0%) and valuation multiples (DSGN N/M vs FHTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DSGN (5) vs FHTX (4)
Institutional Metric DSGN FHTX Criterion Row Winner
Market Capitalization Scale $677.5M $122.9M Larger Scale DSGN
Trailing P/E Ratio Valuation N/M 22.8x Lower Multiple FHTX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +924.7% Higher Growth FHTX
Operating Margin (TTM) Profitability 0.0% 8.0% Higher Margin FHTX
Net Profit Margin Profitability 0.0% 8.4% Higher Margin FHTX
Return on Equity (ROE) Capital Efficiency -36.9% -470.4% Higher ROE DSGN
52-Week Range Position Momentum 30% ($7โ€“$17) 0% ($2โ€“$8) Stronger Trend DSGN
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 61% Vol 1.67ฮฒ ยท 79% Vol Lower Realized Risk DSGN
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 38.2 / 100 (SELL) Higher Composite DSGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DSGN vs FHTX Buy Guide
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FHTX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live FHTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DSGN nor FHTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.